Search Results 591-600 of 18106 for CLL

1. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

2. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

3. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

4. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

5. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

6. Multiple myeloma - Doctors and departments - Mayo Clinic

   Blood Cancers & Disorders Discussions. hikerny · Anyone have chronic lymphocytic leukemia (CLL)?. 42 Replies Sat, Apr 26, 2025.

7. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

8. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

9. Faculty and Staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

   Lymphoma Epidemiology: James R. Cerhan · Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology Resource ...

10. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

    ... CLL/SLL. For CLL/SLL, patients must have received prior therapies, namely a BTK inhibitor or BCL-2 inhibitor. These patients may or may not have received ...